Three Dimensions for Diabetes (3DFD): A novel approach to managing chronic disease?Hamzah MohammedChronic diseases are the leading cause of mortality globally, accounting for more than 70% of the estimated 56 million total deaths recorded in 2017. 1 They are associated with psychiatric comorbidity and social stresses (e.g. debt and unemployment), resulting in suboptimal disease control, risk of complication and increased financial burden on healthcare systems.Diabetes mellitus is a primary example, affecting almost four million people in the United Kingdom and accounting for approximately 10% of the National Health Service expenditure. 2 Depressive symptoms feature in approximately 25% of patients with diabetes and, in addition to social problems such as inadequate housing and isolation, are obstacles in achieving satisfactory glycaemic control.3,4In the evidence-based services that integrate social, psychological and medical care for these patients, an award-winning ‘3 Dimensions for Diabetes’ (3DFD) programme was launched in Greater London and targeted to patients with poorly controlled disease and psychosocial comorbidity.In a non-randomised control pilot study the programme recruited adults with poor glycaemic control and psychiatric and/or social problems from primary and secondary care. 5 Over a twelve-month period, they were compared with a control group who received usual treatment without provision of mental health and social care.The 3DFD intervention comprised a full-time consultant liaison psychiatrist and community support workers from a local voluntary welfare organisation. Dedicated clinics were incorporated into diabetes teams and clinics, and social support outreach delivered from off-site offices or patients’ homes. In addition to routine diabetes care, patients received psychological treatments including cognitive behavioural therapy (CBT) and pharmacotherapy, as well as social interventions where required, examples being debt management and advocacy in housing.The results were positive in favour of 3DFD and support a biopsychosocial model of care for patients with diabetes. When adjusted for confounding, glycaemic control and psychosocial outcomes amongst enrolled participants had improved significantly at twelve-month follow-up compared with the control arm. The associated cost of 3DFD was greater than usual care, though this may be an underestimate given worse glycaemic within the treatment cohort at baseline.This novel integrated care approach raises the prospect of applicability to other chronic diseases where psychiatric and/or social difficulties are common. Epilepsy, for instance, is estimated to affect 600,000 people in the UK and associated with a twenty-fold increased incidence of sudden death compared with the general population.6,7 The increased prevalence of psychiatric disease, compounded by stigma and social restrictions, are predictors of poor quality of life and seizure control, but unfortunately are not adequately addressed. 8,9 Integration of care, with focus of the medical and psychosocial aspects of disease is key to improving patient care and experience.Given the relative success of the 3DFD programme in highlighting the role for an integrated care model in diabetes management, it is worth considering if this approach can be extended to other conditions. Continuing with the example of epilepsy, could the ‘3 Dimensions of Care for Diabetes’ (3DFD) programme pave way for a similar-structured ‘3 Dimensions of Care for Epilepsy’ (3DFE) model?1. Hannah Ritchie and Max Roser (2018) - ”Causes of Death”. Published online at OurWorldInData.org. Retrieved from: ’https://ourworldindata.org/causes-of-death’ [Online Resource]2. Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012;29(7):855-862.3. Holt RI, de Groot M, Golden SH. Diabetes and depression. Curr Diab Rep. 2014;14(6):491.4. Fisher L, Polonsky WH, Hessler DM, et al. Understanding the sources of diabetes distress in adults with type 1 diabetes. J Diabetes Complications. 2015;29(4):572-577.5. Ismail K, Stewart K, Ridge K, et al. A pilot study of an integrated mental health, social and medical model for diabetes care in an inner-city setting: Three Dimensions for Diabetes (3DFD). Diabet Med. 2019.6. Holmes E, Bourke S, Plumpton C. Attitudes towards epilepsy in the UK population: Results from a 2018 national survey. Seizure - European Journal of Epilepsy. 2019;65:12-19.7. Shankar R, Cox D, Jalihal V, Brown S, Hanna J, McLean B. Sudden unexpected death in epilepsy (SUDEP): Development of a safety checklist.Seizure - European Journal of Epilepsy. 2013;22(10):812-817.8. Lin JJ, Mula M, Hermann BP. Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan. Lancet.2012;380(9848):1180-1192.9. Mula M, Sander JW. Psychosocial aspects of epilepsy: a wider approach. BJPsych Open. 2016;2(4):270-274.